Pneumonia News and Research

Latest Pneumonia News and Research

Italian scientists investigate whether stranded cetaceans show evidence of SARS-CoV-2 infection

A new study examines SARS-CoV-2 infection in stranded cetaceans found dead along the Italian coast.

27 Sep 2022

What is the impact of SARS-CoV-2 infection on semen parameters and sex hormones?

A new study aimed to systematically review studies investigating sex hormones and semen parameters in COVID-19 patients to provide a better understanding and treatment approach.

27 Sep 2022

COVID-19 can cause long-term lung damage to children and teens

In a recent study published in the Radiology journal, researchers in Germany assessed the pulmonary dysfunction observed after pediatric coronavirus disease 2019 (COVID-19).

27 Sep 2022

World Sepsis Month: Increasing Sepsis Awareness, Patient Support, and Improving Survivor Outcomes

As part of Sepsis Awareness Month, celebrated annually in September, News Medical Speaks to Dr. Ron Daniels, founder, and chief executive of the UK Sepsis Trust, about the significance of sepsis awareness, support for patients, and improving outcomes for sepsis survivors.

23 Sep 2022

What is the efficacy of aerosol treatment for SARS-CoV-2 infection?

In a new study, researchers assessed the efficacy of the scFv76 antibody against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lung damage.

21 Sep 2022

Genome-based microbiome signature associated with the severity and prognosis of COVID-19 in hospitalized patients

Researchers evaluated the association between guild-level microbiome signature and the severity and prognosis of SARS-CoV-2 infections by a genome-level metagenomic analysis.

21 Sep 2022

BU investigator wins highly competitive awards to study the role of proteases in regulation of cellular defenses

Mohsan Saeed, PhD, assistant professor of biochemistry at Boston University School of Medicine (BUSM), has received a five-year, $2 million R35 grant from the National Institute of General Medical Sciences, as well as a five-year, $2.5 million R01 grant from the National Institute of Allergy and Infectious Diseases.

20 Sep 2022

First multi-center, large-scale registry of severe asthma patients launched in Singapore

A research network formed by Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), Changi General Hospital (CGH), Singapore General Hospital (SGH), and Tan Tock Seng Hospital (TTSH) has set up the Singapore Severe Asthma Registry (SSAR), the first of its kind in the country.

19 Sep 2022

Research examines the roles of cytokines during SARS-CoV-2 infection in rhesus macaques

In a recent study posted to the bioRxiv* preprint server, researchers in the United States assessed the role of two cytokines, interferon-gamma (IFN-γ) and interleukin-10 (IL-10), in regulating immune cell responses and inflammation early during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in rhesus macaques.

18 Sep 2022

One year later, 40% of patients with COVID pneumonia still had lung problems

A recent study published in the journal Respiratory Research found impaired lung function and dyspnea amongst severe COVID-19 pneumonia survivors one year post-infection. Meanwhile, many COVID-19 patients developed fibrotic-like sequelae as an aftermath of the infection-associated mild or severe pneumonia.

15 Sep 2022

R21/Matrix-M booster maintains high efficacy against first and multiple episodes of clinical malaria

The phase 1/2b clinical trial on R21/Matrix-M malaria vaccine has recently reported the safety and efficacy of booster vaccination at 12 months.

15 Sep 2022

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

Researchers identified type 3 vaccine-derived poliovirus (VDPV) in an infant.

13 Sep 2022

N-dihydrogalactochitosan shows promise as a mucosal vaccine adjuvant against SARS-CoV-2

In a recent study posted to the bioRxiv* server, researchers in the United States demonstrated the efficacy of a novel biopolymer, N-dihydrogalactochitosan (GC), as an adjuvant for next-generation mucosal coronavirus disease 2019 (COVID-19) vaccine.

12 Sep 2022

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States.

9 Sep 2022

Research on the antimicrobial effects of human milk oligosaccharides

In a recent review published in the journal Current Opinion in Chemical Biology, researchers discussed the latest advances in the antimicrobial properties of human milk.

9 Sep 2022

Can preclinical COVID-19 models help unlock mystery of long-COVID?

In a recently published article in the journal PLOS PATHOGENS, scientists have summarized acute and prolonged clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The review also provides an overview of the potency and utility of preclinical animal models to understand the mechanistic details of acute and long coronavirus disease 2019 (COVID-19).

8 Sep 2022

Clinical trial begins evaluating alternative strategies to administer the JYNNEOS monkeypox vaccine

A clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine to increase the number of available doses has begun enrolling adult volunteers.

8 Sep 2022

Annual flu shot may be linked with lower risk of stroke

Getting an annual flu shot may be associated with a lower risk of stroke, according to a study published in the September 7, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

8 Sep 2022

How can Legionella pneumophila transmit through the hot water plumbing of residences and office buildings?

Researchers investigate the transmission of the causative agent of legionellosis, Legionella pneumophila, through hot water plumbing systems in commercial and residential buildings.

8 Sep 2022

NIH animal study combines Paxlovid with Lagevrio against SARS-CoV-2 Delta

In a recent study posted to the bioRxiv* preprint server, researchers at the U.S National Institutes of Health demonstrated the efficacy of molnupiravir and nirmatrelvir, two oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antivirals in the rhesus macaque model, the closest proxy to humans.

7 Sep 2022

Pneumonia News and Research

Latest Pneumonia News and Research

Italian scientists investigate whether stranded cetaceans show evidence of SARS-CoV-2 infection

What is the impact of SARS-CoV-2 infection on semen parameters and sex hormones?

COVID-19 can cause long-term lung damage to children and teens

World Sepsis Month: Increasing Sepsis Awareness, Patient Support, and Improving Survivor Outcomes

What is the efficacy of aerosol treatment for SARS-CoV-2 infection?

Genome-based microbiome signature associated with the severity and prognosis of COVID-19 in hospitalized patients

BU investigator wins highly competitive awards to study the role of proteases in regulation of cellular defenses

First multi-center, large-scale registry of severe asthma patients launched in Singapore

Research examines the roles of cytokines during SARS-CoV-2 infection in rhesus macaques

One year later, 40% of patients with COVID pneumonia still had lung problems

R21/Matrix-M booster maintains high efficacy against first and multiple episodes of clinical malaria

Study shows vaccine-derived poliovirus in infant with severe immunodeficiency

N-dihydrogalactochitosan shows promise as a mucosal vaccine adjuvant against SARS-CoV-2

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

Research on the antimicrobial effects of human milk oligosaccharides

Can preclinical COVID-19 models help unlock mystery of long-COVID?

Clinical trial begins evaluating alternative strategies to administer the JYNNEOS monkeypox vaccine

Annual flu shot may be linked with lower risk of stroke

How can Legionella pneumophila transmit through the hot water plumbing of residences and office buildings?

NIH animal study combines Paxlovid with Lagevrio against SARS-CoV-2 Delta

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Pneumonia News and Research

Latest Pneumonia News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in